High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in history

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Switzerland Nachrichten Nachrichten

Switzerland Neuesten Nachrichten,Switzerland Schlagzeilen

MedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 729. in CH
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Pot sector falls into correction territory, but MedMen jumps after $682 million acquisitionMarijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC. CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳 Igc
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Marijuana stocks to watch: MedMen turns a vision into reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality. Ticker isn’t on robinhood?
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

The CEO of the biggest cannabis company in the US reveals his strategy for defending against multi-billion private equity fundsBI PRIME: Hot off of a $682 million acquisition, Adam Bierman, the CEO of MedMen — now the biggest cannabis company in the US — opens up about who his biggest competition is and how he's defending against them.
Herkunft: BusinessInsider - 🏆 729. / 51 Weiterlesen »

'Retail is the place to be' in cannabis, says MedMen CEO after 'blockbuster' PharmaCann acquisitionJim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »

A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisitionBI PRIME: iAnthus, a multistate cannabis dispensary operator, acquired Toronto-based MPX Bioceutical in a $640 million all-stock transaction. The deal comes on the heels of rival MedMen's $682 million acquisition of PharmaCann. BIPrime Are they considering a 'joint' venture?
Herkunft: BusinessInsider - 🏆 729. / 51 Weiterlesen »

Cannabis industry shops for a suit and tieMoney is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
Herkunft: Breakingviews - 🏆 470. / 51 Weiterlesen »

Pot sector falls into correction territory, but MedMen jumps after $682 million acquisitionMarijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC. CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳 Igc
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »